- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-6249
- Umfang
-
Online-Ressource
- Sprache
-
Deutsch
- Anmerkungen
-
online resource.
- Erschienen in
-
Therapeutische Nanobodies gegen SARS-CoV-2 ; volume:28 ; number:1 ; day:13 ; month:2 ; year:2022 ; pages:39-42 ; date:2.2022
Biospektrum ; 28, Heft 1 (13.2.2022), 39-42, 2.2022
- Schlagwort
-
SARS-CoV-2
Deutschland
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12268-022-1684-y
- URN
-
urn:nbn:de:101:1-2022051820434746774423
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Güttler, Thomas
- Dobbelstein, Matthias
- Görlich, Dirk
- SpringerLink (Online service)
Ähnliche Objekte (12)
Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron
High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron
High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron